Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BGL:GR

31.312 EUR 1.518 5.09%

As of 10:54:16 ET on 05/22/2015.

Snapshot for BioGaia AB (BGL)

Open: 30.082 Day's Range: 29.889 - 31.312 Volume: 0
Previous Close: 29.794 52wk Range: 15.940 - 31.312 1-Yr Rtn: +47.07%

Stock Chart for BGL

No chart data available.
  • BGL:GR 30.082
  • 1D
  • 1M
  • 1Y
29.794
Interactive BGL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BGL

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 35.6672
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2015) 8.1100
Est. PEG Ratio -
Market Cap (M EUR) 542.55
Shares Outstanding (M) 16.53
30 Day Average Volume 10
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.20%
Cash Dividend (SEK) 3.4600
Dividend Ex-Date 05/08/2015
5 Year Dividend Growth 28.67%
Next Earnings Announcement 08/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BGL

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BGL

BioGaia AB develops and markets health care products. The Company sells foods with healthy additives that help increase resistance against illnesses, and nutritional products with therapeutic effects for adults and children. BioGaia also sells animal feeds and performs pharmaceutical research in the United States and Sweden. Many products are sold worldwide by license.

Peter RothschildCEO/FounderMargareta HagmanExec VP:Acctg & IR
Urban StrindloevExec VP:Partner & Product DevEamonn ConnollyHead:Research
More Company Profile & Key Executives for BGL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil